Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Rev Esp Enferm Dig ; 115(7): 397-398, 2023 07.
Article in English | MEDLINE | ID: mdl-36353958

ABSTRACT

OBJECTIVE: to analyze a hepatitis C virus (HCV) microelimination strategy targeting vulnerable populations and the influence of the pandemic on its maintenance and outcomes. METHODS: in 2018, the Hepatology Unit implemented an HCV microelimination strategy for patients attending drug addiction care centers and Psychiatry Units such as the Alcoholism Treatment Unit. These centers reported suspected or confirmed cases of HCV infection directly to the hepatologists, who, after reviewing the clinical records, cite those patients if necessary. RESULTS: from June 2018 to February 2020, hepatologists were consulted on 37 anti-HCV positive patients, 31 of them were from Drug Addiction Care Centers, 5 from the Alcoholism Disorders Unit and 1 from the Department of Psychiatry. Fibrosis stage: F0-F1, 18 (50%); F2, 9 (25%); F3, 2 (4.2%); F4, 8 (20.8%). Female sex, 6 (16.7%). Required attending: Yes, 27 (73%). 25 (92.6%) went. Outpatient consultation: 10 (27%). Required treatment: 19 (51.3%). Sustained virological response: 19 (100%). Fibrosis stage of treated patients: F0-F1, 13 (68%); F2, 2 (11%); F3, 1 (5%); F4, 3 (16%). Patients from the Psychiatry Department during 2021: 11. 9 (82%) do not need to attend; 2 (18%): their situation is unknown. CONCLUSIONS: sustained communication with centers that care for populations at risk of active HCV infection is needed to detect cases, increase adherence to treatment, and rescue patients who require screening for hepatocarcinoma.


Subject(s)
Alcoholism , Hepatitis C, Chronic , Hepatitis C , Liver Neoplasms , Substance-Related Disorders , Female , Humans , Antiviral Agents/therapeutic use , Hepacivirus , Hepatitis C/epidemiology , Hepatitis C/prevention & control , Hepatitis C/drug therapy , Hepatitis C, Chronic/drug therapy , Liver Cirrhosis/pathology , Liver Neoplasms/drug therapy , Pandemics , Substance-Related Disorders/drug therapy , Vulnerable Populations , Male
4.
Rev. esp. enferm. dig ; 108(11): 741-742, nov. 2016. tab, ilus
Article in Spanish | IBECS | ID: ibc-157571

ABSTRACT

Los tumores de células epiteliodes perivasculares son tumores de células epiteliales vasculares con características inmunohistoquímicas de músculo liso y células melanocíticas. Los gastrointestinales son infrecuentes. El tratamiento es quirúrgico aunque existen datos que indican buena respuesta a la rapamicina (AU)


Perivascular epithelioid cell tumors (PEComa) are tumors of perivascular epithelioid cells with immunohistochemical features of smooth muscle and melanocytic tumors. The PEComa of the gastrointestinal tract is rare. The treatment is surgical, although there are data that suggest a good response to rapamycin (AU)


Subject(s)
Humans , Male , Adult , Ileal Neoplasms/diagnosis , Ileal Neoplasms/drug therapy , Ileal Neoplasms/pathology , Perivascular Epithelioid Cell Neoplasms/surgery , Sirolimus/therapeutic use , Perivascular Epithelioid Cell Neoplasms/diagnosis , Perivascular Epithelioid Cell Neoplasms/pathology , Immunohistochemistry/instrumentation , Immunohistochemistry/methods
5.
Rev Esp Enferm Dig ; 108(11): 741-742, 2016 Nov.
Article in English | MEDLINE | ID: mdl-26900883

ABSTRACT

Perivascular epithelioid cell tumors (PEComa) are tumors of perivascular epithelioid cells with immunohistochemical features of smooth muscle and melanocytic tumors. The PEComa of the gastrointestinal tract is rare. The treatment is surgical, although there are data that suggest a good response to rapamycin.


Subject(s)
Ileal Neoplasms/diagnostic imaging , Perivascular Epithelioid Cell Neoplasms/diagnostic imaging , Humans , Ileal Neoplasms/surgery , Ileum/diagnostic imaging , Ileum/pathology , Male , Perivascular Epithelioid Cell Neoplasms/surgery , Tomography, X-Ray Computed , Treatment Outcome , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...